
NZM7
NZM7 is an adherent metastatic melanoma cell line derived from the cervical lymph node of a 36 year old male patient.
[Create a profile and sign in to view pricing and add to cart]
- Description
- Ask a Question
Description
Description: NZM7 is an adherent metastatic melanoma cell line derived from the cervical lymph node of a 36 year old male patient.
Description Key Words: Human metastatic melanoma from cervical lymph node
Also Known As: No other names
Organism: Human (Homo sapiens)
Tissue: Melanoma metastatic from cervical lymph node
Growth Properties: Adherent
Doubling Time: 49 hours
Morphology: Heterogeneous morphology with elongated cells
Growth Medium: This cell line was established by the depositor in: Alpha modified Minimum Essential Medium (MEM) supplemented with 5% Foetal Bovine Serum (FBS)”, 5 ug/ml Insulin, 5 ug/ml Transferrin, 5 ng/ml Sodium Selenite (ITS), in an atmosphere of 5%O2, 5%CO2 and 90%N2.
At CellBank Australia it has been cultured in: Alpha modified Minimum Essential Medium (MEM) supplemented with 10% Foetal Bovine Serum (FBS)”, 5 ug/ml Insulin, 5 ug/ml Transferrin, 5 ng/ml Sodium Selenite (ITS), in an atmosphere of 5%CO2.
Resuscitation: Remove protective cryoflex layer around the ampoule prior to thawing. Thaw the ampoule by gently agitating in a 37°C waterbath; thawing should be rapid (around 2 minutes). A centrifugation step to remove the cryoprotectant after thawing is necessary for this cell line.
Subculturing Procedure:
Medium Renewal: 2-3 times per week.
Subcultivation Ratio: 1:4 – 1:8 Seeding density 1.3 x104cells/cm2. Split subconfluent cultures(70-80%). Harvest the cells using 0.05% Trypsin/EDTA at 37°C for 5 minutes.
Culture Conditions: Incubate the culture at 37°C with 5% CO2.
Cryoprotectant Medium: 10% DMSO + 90% FCS
Handling Procedure for Frozen Cells: Upon receipt, frozen ampoules should be transferred directly to liquid nitrogen storage without delay, if not to be used immediately. Storage at -80°C may result in loss of viability.
Additional Information:
_ Aneuploid 2.18x diploid 55-59 chromosomes per cell
_ Mutations:
- Wild-type for CDKN2A/B, PIK3CA, NRAS
- BRAF V600E mutation
- Heterogeneous for p53 mutation: some cells with p53 mutation 241S/P
_ Resistant to temozolomide
_ MGMT expressed
Depositor: Professor Bruce Baguley – The University of Auckland, New Zealand
Reference:
Original Reference:
Marshall ES, Matthews JHL, Shaw JHF, Nixon J, Tumewu P, Finlay GJ, Holdaway KM, Baguley BC.
Radiosensitivity testing of human melanoma cell lines: comparison of [3H]-thymidine incorporation and soft agar clonogenic assays.
Eur J Cancer 1994; 30A: 1370-1376.
PubMed 7999427
Cellosaurus: CVCL_D843
Ask a Question
Have a question about this product? Our technical team is here to help.



